Alyssa Degrace LGPC

Recommended Articles

• Celiac Vaccine Moves to Phase 2!

  For a celiac patient,  a perfect world is when they can sit down at any table and tuck into a meal without worrying about gluten.  This perfect world could become a reality, thanks to the development of a vaccine designed to treat the disease. Because the vaccine has been so successful in its...

• What are the Causes and Symptoms of Psoriasis?

  Psoriasis is a chronic skin condition that results in the formation of thick, reddish patches on the skin, often with a scaly appearance. This is a condition resulting from changes in the normal life cycle of skin cells. Under normal conditions, new skin cells grow and replace the old ones on the...

• What is Post-Traumatic Stress Disorder?

  Post-traumatic stress disorder, or PTSD, is an anxiety disorder that a person develops after witnessing a very stressful and terrifying event. In most cases, the person must have faced a life-threatening event or an incident in which serious injury was involved. Events that trigger fear,...

• Is Schizophrenia Fatal?

  Schizophrenia by itself is not fatal like cancer or any other life-threatening diseases. However, many cases of death have been accounted for and the usual reason behind it is suicide. Moreover, people who have adopted habits such as smoking, taking prohibited drugs, or unhealthy eating, either due...

• Do Shin Splints Require Physical Therapy?

  Shin splints are also known as medial tibial stress syndrome (MTSS). The pain along the inner aspect of your shin bone is referred to as a shin splint. This condition is common in athletes and those who participate in high-intensity workouts, and in sports like basketball, tennis, soccer, and...

• $5.8 Million Grant Given to Develop New Immunotherapy for Ovarian Cancer

  Ovarian cancer cells can be extremely tricky to get rid of, which makes treatment often expensive and prolonged. Researchers at the University of California San Diego recently received a 5.8-million-dollar grant from the state to develop a new form of immunotherapy for ovarian cancer.The StudyThe...